November 15, 2022
On November 14, 2022, the Business Leaders’ Coalition for Global Health (led by Ken Shibusawa, CEO, Shibusawa and Company, Inc., hereinafter “the Coalition”), in which Eisai participates, visited Mr. Yoshimasa Hayashi, Minister of Foreign Affairs, and handed him a ” Request for Revision of the Development Cooperation Charter”. Haruo Naito, CEO and Representative Executive Officer of Eisai, also participated in the event.
The Government of Japan has announced that it will revise the Development Cooperation Charter, which sets out the basic policy for development cooperation policy, to make it more effective and strategic in light of major changes in circumstances since the formulation of the Development Cooperation Charter in 2015, and will formulate a new Development Cooperation Charter around the first half of next year. In the letter of request, the Coalition noted following points: (1) positioning global health as a major pillar of the Development Cooperation Charter and demonstrating international leadership; (2) establishing a public-private partnership system to encourage private sector’s contribution to global health; and (3) promoting human resource development in low- and middle-income countries to prepare for pandemics.
Eisai’s initiatives for improving access to medicines aimed at elimination of NTDs and malaria, go beyond the framework of CSR activities and aim at creating long-term value and social impact based on our corporate concept, human health care (hhc). We aim to contribute to relieving anxiety over health and reducing health disparities of people at risk of contracting neglected tropical diseases and those suffering from diseases by strengthening our global partnerships.
About the Business Leaders’ Coalition for Global Health
The Business Leaders’ Coalition for Global Health (supporting and actively working in the fields of healthcare, especially public health and infectious disease control), led by Ken Shibusawa (CEO, Shibusawa & Company, Inc.). It is composed of executives from a wide variety of fields, including not only the healthcare sector, such as pharmaceuticals and medical devices, but also finance, trading, digital, supply chain, and more. Haruo Naito, Eisai’s CEO, is a member.
The Coalition believes that by optimizing the products and technologies of diverse sectors, including governments, we can provide comprehensive solutions to global issues, and to this end, the volunteer companies will work together under the same vision to promote Global Health Action. The Coalition is considering the following four initiatives for the future. (Not all volunteer companies will participate in these initiatives.)
1.Consider specialized schemes and entities that promote the creation and strengthening of opportunities to collaborate with international health organizations such as WHO, Global Fund, Gavi Vaccine Alliance, etc.
Establish an All-Japan pavilion at international exhibitions and promotion of the advanced and attractivefeatures of Japanese products that contribute to global health
3.Promote the introduction and participation in a system of “impact-weighted accounting” that quantifies and visualizes the impact of socially conscious products
4.Continue activities to bring corporate voices on international health issues to the government